VirtualScopics, a provider of quantitative imaging for clinical trials, has opened an office in central Europe, a second European location joining the UK office which opened in 2008, to focus on its growing portfolio of international customers.

The new office is expected to initially be staffed by a senior project manager who joins the company with an extensive background in global clinical trial management with pharmaceutical companies.

Jeff Markin, chief executive officer, said: “As a global company, we are very excited to expand our presence with this office in central Europe. With a thriving international customer base it is vital that we provide dedicated services to better meet the needs of our clients.

“Combined with our UK office, we are able to offer devoted business development, site management, and project management services to our international customers.”

VirtualScopics is a provider of imaging solutions to accelerate medical device development. The company has developed a software platform for analysis and modeling of both structural and functional medical images.

In combination with VirtualScopics’ experience and expertise in advanced imaging biomarker measurement, the platform provides a clear window into the biological activity of devices in clinical trial patients, to allow better decisions faster.